Grant: Discovery Grants Program - Individual
McMaster University
$69,000.00
High Throughput Microarray Printing and Imaging Methods to Develop new Bioactive Materials for Sensing and Small Molecule Screening
EF 2017-18
Résumé
My NSERC-supported research program will develop and utilize high throughput, microarray and microwell plate-based methods to synthesize and characterize advanced sol-gel based bioactive materials that will transform solid-phase assays used in diagnostics and drug discovery. These new materials will be used for printing biologicals (proteins, aptamers, cells) as microarrays, or to prepare monolithic bioaffinity columns that can be used for screening of complex mixtures or extracts. High throughput screening will be used to identify materials with desired properties (i.e., high bioactivity, low non-specific binding, appropriate porosity, etc) and will allow us to hone in on optimal materials more rapidly, while providing an abundance of data that will allow us to better understand and control the properties of our materials. Key objectives over the next 5 years are: (1) establishment and implementation of automated methods to allow high-throughput synthesis, screening and characterization of improved sol-gel materials with entrapped biomolecules, including new studies of how proteins, DNA/RNA aptamers and cells behave within sol-gel based materials; (2) development of a database of biointeface interactions (DBI) to aid in cataloging, mining and modeling of HT materials data; (3) use of advanced printing methods to prepare improved sol-gel based microarrays for new applications utilizing proteins, cells and aptamers, with characterization by high-throughput microarray imaging methods based on MALDI-MS, XPS, FTIR, SPR and fluorescence; and (4) in-depth studies to optimize sol-gel material properties for biosensing, affinity chromatography and immobilized enzyme reactors. This research will provide critical data to enhance our understanding of materials and optimize them for a given application. It will transform our understanding of the interface between surfaces and biological species (particularly cells), and will provide new insights into how to design such materials to optimize biomolecule properties. It will result in novel ""bioactive"" interfaces and new devices such as protein and reporter-gene cell microarrays for prognostics and diagnostics, new bioseparation media and new tools for small molecule screening.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
184073-2013
Name nom
Brennan, John
Department département
Chemistry & Chemical Biology
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2013
Award amount
69000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
5
Nb partie
5
Application title
High Throughput Microarray Printing and Imaging Methods to Develop new Bioactive Materials for Sensing and Small Molecule Screening
Keyword
NSERC
Application summary
My NSERC-supported research program will develop and utilize high throughput, microarray and microwell plate-based methods to synthesize and characterize advanced sol-gel based bioactive materials that will transform solid-phase assays used in diagnostics and drug discovery. These new materials will be used for printing biologicals (proteins, aptamers, cells) as microarrays, or to prepare monolithic bioaffinity columns that can be used for screening of complex mixtures or extracts. High throughput screening will be used to identify materials with desired properties (i.e., high bioactivity, low non-specific binding, appropriate porosity, etc) and will allow us to hone in on optimal materials more rapidly, while providing an abundance of data that will allow us to better understand and control the properties of our materials. Key objectives over the next 5 years are: (1) establishment and implementation of automated methods to allow high-throughput synthesis, screening and characterization of improved sol-gel materials with entrapped biomolecules, including new studies of how proteins, DNA/RNA aptamers and cells behave within sol-gel based materials; (2) development of a database of biointeface interactions (DBI) to aid in cataloging, mining and modeling of HT materials data; (3) use of advanced printing methods to prepare improved sol-gel based microarrays for new applications utilizing proteins, cells and aptamers, with characterization by high-throughput microarray imaging methods based on MALDI-MS, XPS, FTIR, SPR and fluorescence; and (4) in-depth studies to optimize sol-gel material properties for biosensing, affinity chromatography and immobilized enzyme reactors. This research will provide critical data to enhance our understanding of materials and optimize them for a given application. It will transform our understanding of the interface between surfaces and biological species (particularly cells), and will provide new insights into how to design such materials to optimize biomolecule properties. It will result in novel ""bioactive"" interfaces and new devices such as protein and reporter-gene cell microarrays for prognostics and diagnostics, new bioseparation media and new tools for small molecule screening.